PRODUCTS
APIs
ATORVASTATIN CALCIUM
APIXABAN
AGOMELATINE
BICTEGRAVIR
BALOXAVIR MARBOXIL
CAPTOPRIL
CHLOROTHIAZIDE
CANAGLIFLOZIN
DOXYCYCLINE MONOHYDRATE
DOXYCYCLINE HYCLATE
DACLATASVIR DIHYDROCHLORIDE
DABIGATRAN ETEXILATE MESYLATE
ENALAPRIL MALEATE
EZETIMIBE
FOLIC ACID
HYDROCHLOROTHIAZIDE
LENALIDOMIDE
LEDIPASVIR ACTONE/PVP
NIRAPARIB
OBETICHOLIC ACID
PREGABALIN
PITAVASTATIN CALCIUM
ROSUVASTATIN CALCIUM
RIBOCICLIB
RIVAROXABAN
SOFOSBUVIR
SACUBITRIL HEMICALCIUM
SUGAMMADEX SODIUM
TOFACITINIB CITRATE
TICAGRELOR
THALIDOMIDE
VALSARTAN/SACUBITRIL 3NA-2.5 H2O
VENETOCLAX
Finished dosage formulations
pharmaceutical factory
Home >> R & D

There are three labs that are responsible for research and development of APIs, finished dosages and genetic engineering drugs respectively. More than 4O technicians are employed in the R&D laboratories, including several Doctors and Masters. The API lab has a pilot scale workshop, and is focused on new products process researches, lab and pilot scale trial production research and process optimization and commercial launching research.